Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 5348

Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
In 2018, the global Intravenous Immune Globulin Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous Immune Globulin Therapies development in United States, Europe and China.

The key players covered in this study
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical

Market segment by Type, the product can be split into
Liquid Form
Lyophilized Powder Form

Market segment by Application, split into
Immunodeficiency
Autoimmune Disease
Acute Infection

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players.
To present the Intravenous Immune Globulin Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Intravenous Immune Globulin Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Liquid Form
1.4.3 Lyophilized Powder Form
1.5 Market by Application
1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application (2014-2025)
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Intravenous Immune Globulin Therapies Market Size
2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions (2014-2025)
2.2.2 Intravenous Immune Globulin Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Intravenous Immune Globulin Therapies Market Size by Manufacturers
3.1.1 Global Intravenous Immune Globulin Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
3.3 Key Players Intravenous Immune Globulin Therapies Product/Solution/Service
3.4 Date of Enter into Intravenous Immune Globulin Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Intravenous Immune Globulin Therapies Market Size by Type (2014-2019)
4.2 Global Intravenous Immune Globulin Therapies Market Size by Application (2014-2019)

5 United States
5.1 United States Intravenous Immune Globulin Therapies Market Size (2014-2019)
5.2 Intravenous Immune Globulin Therapies Key Players in United States
5.3 United States Intravenous Immune Globulin Therapies Market Size by Type
5.4 United States Intravenous Immune Globulin Therapies Market Size by Application

6 Europe
6.1 Europe Intravenous Immune Globulin Therapies Market Size (2014-2019)
6.2 Intravenous Immune Globulin Therapies Key Players in Europe
6.3 Europe Intravenous Immune Globulin Therapies Market Size by Type
6.4 Europe Intravenous Immune Globulin Therapies Market Size by Application

7 China
7.1 China Intravenous Immune Globulin Therapies Market Size (2014-2019)
7.2 Intravenous Immune Globulin Therapies Key Players in China
7.3 China Intravenous Immune Globulin Therapies Market Size by Type
7.4 China Intravenous Immune Globulin Therapies Market Size by Application

8 Japan
8.1 Japan Intravenous Immune Globulin Therapies Market Size (2014-2019)
8.2 Intravenous Immune Globulin Therapies Key Players in Japan
8.3 Japan Intravenous Immune Globulin Therapies Market Size by Type
8.4 Japan Intravenous Immune Globulin Therapies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2014-2019)
9.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia
9.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type
9.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application

10 India
10.1 India Intravenous Immune Globulin Therapies Market Size (2014-2019)
10.2 Intravenous Immune Globulin Therapies Key Players in India
10.3 India Intravenous Immune Globulin Therapies Market Size by Type
10.4 India Intravenous Immune Globulin Therapies Market Size by Application

11 Central & South America
11.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2014-2019)
11.2 Intravenous Immune Globulin Therapies Key Players in Central & South America
11.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type
11.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application

12 International Players Profiles
12.1 Baxter
12.1.1 Baxter Company Details
12.1.2 Company Description and Business Overview
12.1.3 Intravenous Immune Globulin Therapies Introduction
12.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Company Details
12.2.2 Company Description and Business Overview
12.2.3 Intravenous Immune Globulin Therapies Introduction
12.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.2.5 Grifols Recent Development
12.3 CSL Plasma
12.3.1 CSL Plasma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Intravenous Immune Globulin Therapies Introduction
12.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.3.5 CSL Plasma Recent Development
12.4 Octapharma
12.4.1 Octapharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Intravenous Immune Globulin Therapies Introduction
12.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Company Details
12.5.2 Company Description and Business Overview
12.5.3 Intravenous Immune Globulin Therapies Introduction
12.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Company Details
12.6.2 Company Description and Business Overview
12.6.3 Intravenous Immune Globulin Therapies Introduction
12.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.6.5 Kedrion Recent Development
12.7 Kamada
12.7.1 Kamada Company Details
12.7.2 Company Description and Business Overview
12.7.3 Intravenous Immune Globulin Therapies Introduction
12.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.7.5 Kamada Recent Development
12.8 China Biologic Products Holdings
12.8.1 China Biologic Products Holdings Company Details
12.8.2 Company Description and Business Overview
12.8.3 Intravenous Immune Globulin Therapies Introduction
12.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.8.5 China Biologic Products Holdings Recent Development
12.9 Hualan Biological Engineering
12.9.1 Hualan Biological Engineering Company Details
12.9.2 Company Description and Business Overview
12.9.3 Intravenous Immune Globulin Therapies Introduction
12.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.9.5 Hualan Biological Engineering Recent Development
12.10 Sichuan Yuanda Shuyang Pharmaceutical
12.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Intravenous Immune Globulin Therapies Introduction
12.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details